| Literature DB >> 28097270 |
José Medina-Polo1, Raquel Sopeña-Sutil1, Raúl Benítez-Sala1, Alba Lara-Isla1, Manuel Alonso-Isa1, Javier Gil-Moradillo1, Juan Justo-Quintas1, Esther García-Rojo1, Daniel Antonio González-Padilla1, Juan Bautista Passas-Martínez1, Ángel Tejido-Sánchez1.
Abstract
PURPOSE: Healthcare-associated infections (HAIs) in urological patients have special features due to specific risk factors. Our objective was to evaluate the characteristics and risk factors for HAIs in patients hospitalized in a Urology ward.Entities:
Keywords: Hospital Urology Department; Infection control; Multiple drug resistance; Surgical wound infections; Urinary tract infections
Mesh:
Substances:
Year: 2017 PMID: 28097270 PMCID: PMC5240291 DOI: 10.4111/icu.2017.58.1.61
Source DB: PubMed Journal: Investig Clin Urol ISSN: 2466-0493
Descriptive analysis of demographic characteristics and risk factors of patients admitted to the Urology ward (2012–2015)
| Variable | Patients who did not report any HAI during hospitalization (n=6,131) | Patients who reported any HAI during hospitalization (n=415) | p-value |
|---|---|---|---|
| Patients admitted to the Urology ward (%) | 93.7 | 6.3 | |
| Demographics | |||
| Age (y) | 63.8±16.74 | 66.4±14.89 | 0.001 |
| Sex (%), male:female | 74.7%:25.3% | 77.1%:22.9% | 0.274 |
| ASA | <0.001 | ||
| I | 613/4,688 (13.1) | 27/291 (9.3) | |
| II | 2,351/4,688 (50.1) | 114/291 (39.2) | |
| III | 1,459/4,688 (31.1) | 122/291 (41.9) | |
| IV | 265/4,688 (5.7) | 28/291 (9.6) | |
| Comorbidities | |||
| Arterial hypertension | 2,683/6,131 (43.8) | 206/415 (49.6) | 0.020 |
| Diabetes mellitus | 1,088/6,131 (17.7) | 76/415 (18.3) | 0.770 |
| Heart disease | 1,211/6,131 (19.8) | 96/415 (23.1) | 0.095 |
| Liver disease | 254/6,131 (4.1) | 24/415 (5.8) | 0.109 |
| Immunosuppressiona | 260/6,131 (4.2) | 35/415 (8.4) | <0.001 |
| Urologic risk factors | |||
| Urinary lithiasis | 1,143/6,131 (18.6) | 57/415 (13.7) | 0.012 |
| Prior urinary infection | 145/6,131 (2.4) | 32/415 (7.7) | <0.001 |
| Urinary catheter before admission | 1,105/6,131 (18.0) | 140/415 (33.7) | <0.001 |
| Urinary catheter during hospitalization | 4,553/6,131 (74.3) | 342/415 (82.4) | <0.001 |
| Surgery during hospitalization | 4,652/6,131 (75.9) | 300/415 (72.3) | 0.099 |
| Hospitalization period (d) | 5.3±6.10 | 17.3±16.58 | <0.001 |
Values are presented as mean±standard deviation or number (%) unless otherwise indicated.
HAI, Healthcare-associated infection; ASA, American Society of Anesthesiologists physical status classification system.
a:Immunosuppression includes patients who suffer hematological neoplasms such as leukemia, lymphoma, multiple myeloma, acquired immunodeficiency syndrome and treatment with immunosuppressa drugs.
Evolution of types of HAIs in patients hospitalized in a Urology ward
| HAI | HAIs 2012 (n=116) | HAIs 2013 (n=113) | HAIs 2014 (n=105) | HAIs 2015 (n=94) | HAIs 2012-2015 (n=428) |
|---|---|---|---|---|---|
| Urinary infections | 76/116 (65.5) | 75/113 (66.4) | 84/105 (80.0) | 67/94 (71.3) | 302/428 (70.6) |
| Surgical site infections | 35/116 (30.2) | 28/113 (24.8) | 15/105 (14.3) | 17/94 (18.1) | 95/428 (22.2) |
| Vascular catheter-associated bacteriemia | 5/116 (4.3) | 8/113 (7.1) | 6/105 (5.7) | 8/94 (8.5) | 27/428 (6.3) |
| Pneumonia | 0/116 (0) | 2/113 (1.8) | 0/105 (0) | 2/94 (2.1) | 4/428 (0.9) |
Values are presented as number (%).
HAI, Healthcare-associated infection.
Four hundered twenty-eight HAIs were reported in 415 patients.
Binary logistic regression analysis evaluating risk factors for HAIs in patients admitted to Urology ward
| p-value | OR | 95% CI | |
|---|---|---|---|
| Age | 0.110 | 0.992 | (0.983–1.002) |
| ASA | <0.001 | 1.391 | (1.155–1.673) |
| Arterial hypertension | 0.632 | 1.067 | (0.818–1.394) |
| Immunosuppressiona | 0.013 | 1.806 | (1.132–2.880) |
| Prior urinary infection | <0.001 | 4.465 | (2.327–8.570) |
| Urinary catheter before admission | <0.001 | 1.746 | (1.322–2.305) |
| Urinary catheter during hospitalization | 0.117 | 1.368 | (0.924–2.025) |
HAI, Healthcare-associated infection; OR, odds ratio; CI, confidence interval; ASA, American Society of Anesthesiologists physical status classification system.
a:Immunosuppression includes patients who suffer hematological neoplasms such as leukemia, lymphoma, multiple myeloma, acquired immunodeficiency syndrome and treatment with immunosuppressant drugs.
Fig. 1Microorganisms isolated in patients with Healthcare-associated infections in the Urology ward.
Resistance patterns of the most frequently isolated microorganisms
| Resistance pattern | |||||
|---|---|---|---|---|---|
| Ampicillin/Amoxicillin | 80.0% | 74.4% | 93.5% | 26.7% | - |
| Amoxicillin + beta-lactamase inhibitor | 45.2% | 34.9% | 54.3% | 7.3% | - |
| Piperacillin/Tazobactam | - | - | - | - | 40.5% |
| Cefuroxime | 51.1% | 37.2% | 54.3% | - | - |
| Ceftriaxone | 39.3% | 29.1% | 52.2% | - | - |
| Ceftazidime | - | 22.4% | 34.9% | - | 40.5% |
| Cefepime | 30.4% | 22.1% | 50.0% | - | 43.9% |
| ESBL-producing bacteria | 34.3% | 24.7% | 47.8% | - | - |
| Carbapenems | 4.4% | 0.0% | 4.3% | - | 33.3% |
| Fluoroquinolones | 46.3% | 53.5% | 47.8% | 50.0% | 54.8% |
| Co-trimoxazole | 34.3% | 38.7% | 35.6% | - | - |
| Gentamicin | 21.8% | 22.1% | 31.1% | 44.1% | 38.1% |
| Amikacin | 8.6% | 9.3% | 7.1% | - | 26.2% |
| Fosfomycin | 18.0% | 7.1% | 28.9% | - | - |
| Nitrofurantoin | - | 6.0% | 29.5% | - | - |
| Vancomycin | - | - | - | 1.7% | - |
E. coli, Escherichia coli; ESBL, extended-spectrum betalactamase.